<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 25 Feb 2026 11:38:00 +0000</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  144        RetinalGenix Technologie               Filed by: BAYERN STEVEN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/26057770.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26057770.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/26057770.html</guid>
   <pubDate>Wed, 25 Feb 2026 11:38:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  144        RetinalGenix Technologie               Filed by: BAYERN STEVEN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/26057770.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26057770.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/26057770.html</guid>
   <pubDate>Wed, 25 Feb 2026 11:38:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO</title>
   <link>http://www.streetinsider.com/Press+Releases/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</link>
   <description>
&lt;p&gt;APOLLO BEACH, Fla., Dec.  08, 2025  (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, combined with advanced genetic testing, today announced the signing of an agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026. Mr. Zwerling brings more than three decades of global experience in healthcare, finance, and operations across pharmaceuticals, medical imaging, biotechnology, and digital health.&lt;/p&gt;  &lt;p&gt;“As the Company prepares for commercialization, RetinalGenix requires a financial, strategic, and operational leader who understands regulated medical</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</guid>
   <pubDate>Mon, 08 Dec 2025 19:43:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32657771</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01150339</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO</title>
   <link>http://www.streetinsider.com/Press+Releases/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</link>
   <description>
&lt;p&gt;APOLLO BEACH, Fla., Dec.  08, 2025  (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, combined with advanced genetic testing, today announced the signing of an agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026. Mr. Zwerling brings more than three decades of global experience in healthcare, finance, and operations across pharmaceuticals, medical imaging, biotechnology, and digital health.&lt;/p&gt;  &lt;p&gt;“As the Company prepares for commercialization, RetinalGenix requires a financial, strategic, and operational leader who understands regulated medical</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</guid>
   <pubDate>Mon, 08 Dec 2025 19:43:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32657771</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01150339</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO</title>
   <link>http://www.streetinsider.com/Press+Releases/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</link>
   <description>
&lt;p&gt;APOLLO BEACH, Fla., Dec.  08, 2025  (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, combined with advanced genetic testing, today announced the signing of an agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026. Mr. Zwerling brings more than three decades of global experience in healthcare, finance, and operations across pharmaceuticals, medical imaging, biotechnology, and digital health.&lt;/p&gt;  &lt;p&gt;“As the Company prepares for commercialization, RetinalGenix requires a financial, strategic, and operational leader who understands regulated medical</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</guid>
   <pubDate>Mon, 08 Dec 2025 19:43:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32657771</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01150339</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO</title>
   <link>http://www.streetinsider.com/Press+Releases/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</link>
   <description>
&lt;p&gt;APOLLO BEACH, Fla., Dec.  08, 2025  (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, combined with advanced genetic testing, today announced the signing of an agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026. Mr. Zwerling brings more than three decades of global experience in healthcare, finance, and operations across pharmaceuticals, medical imaging, biotechnology, and digital health.&lt;/p&gt;  &lt;p&gt;“As the Company prepares for commercialization, RetinalGenix requires a financial, strategic, and operational leader who understands regulated medical</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</guid>
   <pubDate>Mon, 08 Dec 2025 19:43:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32657771</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01150339</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO</title>
   <link>http://www.streetinsider.com/Globe+Newswire/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</link>
   <description>
&lt;p&gt;APOLLO BEACH, Fla., Dec.  08, 2025  (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, combined with advanced genetic testing, today announced the signing of an agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026. Mr. Zwerling brings more than three decades of global experience in healthcare, finance, and operations across pharmaceuticals, medical imaging, biotechnology, and digital health.&lt;/p&gt;  &lt;p&gt;“As the Company prepares for commercialization, RetinalGenix requires a financial, strategic, and operational leader who understands regulated medical</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</guid>
   <pubDate>Mon, 08 Dec 2025 19:43:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32657771</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01150339</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO</title>
   <link>http://www.streetinsider.com/Globe+Newswire/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</link>
   <description>
&lt;p&gt;APOLLO BEACH, Fla., Dec.  08, 2025  (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, combined with advanced genetic testing, today announced the signing of an agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026. Mr. Zwerling brings more than three decades of global experience in healthcare, finance, and operations across pharmaceuticals, medical imaging, biotechnology, and digital health.&lt;/p&gt;  &lt;p&gt;“As the Company prepares for commercialization, RetinalGenix requires a financial, strategic, and operational leader who understands regulated medical</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</guid>
   <pubDate>Mon, 08 Dec 2025 19:43:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32657771</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01150339</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO</title>
   <link>http://www.streetinsider.com/Globe+Newswire/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</link>
   <description>
&lt;p&gt;APOLLO BEACH, Fla., Dec.  08, 2025  (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, combined with advanced genetic testing, today announced the signing of an agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026. Mr. Zwerling brings more than three decades of global experience in healthcare, finance, and operations across pharmaceuticals, medical imaging, biotechnology, and digital health.&lt;/p&gt;  &lt;p&gt;“As the Company prepares for commercialization, RetinalGenix requires a financial, strategic, and operational leader who understands regulated medical</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</guid>
   <pubDate>Mon, 08 Dec 2025 19:43:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32657771</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01150339</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO</title>
   <link>http://www.streetinsider.com/Globe+Newswire/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</link>
   <description>
&lt;p&gt;APOLLO BEACH, Fla., Dec.  08, 2025  (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, combined with advanced genetic testing, today announced the signing of an agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026. Mr. Zwerling brings more than three decades of global experience in healthcare, finance, and operations across pharmaceuticals, medical imaging, biotechnology, and digital health.&lt;/p&gt;  &lt;p&gt;“As the Company prepares for commercialization, RetinalGenix requires a financial, strategic, and operational leader who understands regulated medical</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/RetinalGenix+Technologies+Agrees+To+Hire+M.+Cory+Zwerling+as+CFO%2C+Interim+COO/25713584.html</guid>
   <pubDate>Mon, 08 Dec 2025 19:43:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32657771</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01150339</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  10-Q       RetinalGenix Technologie  For: Sep 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++RetinalGenix+Technologie++For%3A+Sep+30/25617635.html</link>
   <description>si-local-file:///var/storage/secattach/20251114/25617635.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++RetinalGenix+Technologie++For%3A+Sep+30/25617635.html</guid>
   <pubDate>Fri, 14 Nov 2025 16:21:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  10-Q       RetinalGenix Technologie  For: Sep 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++RetinalGenix+Technologie++For%3A+Sep+30/25617635.html</link>
   <description>si-local-file:///var/storage/secattach/20251114/25617635.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++RetinalGenix+Technologie++For%3A+Sep+30/25617635.html</guid>
   <pubDate>Fri, 14 Nov 2025 16:21:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  144        RetinalGenix Technologie               Filed by: BAYERN STEVEN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/25578347.html</link>
   <description>si-local-file:///var/storage/secattach/20251107/25578347.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/25578347.html</guid>
   <pubDate>Fri, 07 Nov 2025 16:05:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  144        RetinalGenix Technologie               Filed by: BAYERN STEVEN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/25578347.html</link>
   <description>si-local-file:///var/storage/secattach/20251107/25578347.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/25578347.html</guid>
   <pubDate>Fri, 07 Nov 2025 16:05:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  10-Q/A     RetinalGenix Technologie  For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-QA+++++RetinalGenix+Technologie++For%3A+Jun+30/25226917.html</link>
   <description>si-local-file:///var/storage/secattach/20250820/25226917.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-QA+++++RetinalGenix+Technologie++For%3A+Jun+30/25226917.html</guid>
   <pubDate>Wed, 20 Aug 2025 06:02:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  10-Q/A     RetinalGenix Technologie  For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-QA+++++RetinalGenix+Technologie++For%3A+Jun+30/25226917.html</link>
   <description>si-local-file:///var/storage/secattach/20250820/25226917.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-QA+++++RetinalGenix+Technologie++For%3A+Jun+30/25226917.html</guid>
   <pubDate>Wed, 20 Aug 2025 06:02:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  10-Q       RetinalGenix Technologie  For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++RetinalGenix+Technologie++For%3A+Jun+30/25224575.html</link>
   <description>si-local-file:///var/storage/secattach/20250819/25224575.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++RetinalGenix+Technologie++For%3A+Jun+30/25224575.html</guid>
   <pubDate>Tue, 19 Aug 2025 16:07:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  10-Q       RetinalGenix Technologie  For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++RetinalGenix+Technologie++For%3A+Jun+30/25224575.html</link>
   <description>si-local-file:///var/storage/secattach/20250819/25224575.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++RetinalGenix+Technologie++For%3A+Jun+30/25224575.html</guid>
   <pubDate>Tue, 19 Aug 2025 16:07:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  NT 10-Q    RetinalGenix Technologie  For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++RetinalGenix+Technologie++For%3A+Jun+30/25199561.html</link>
   <description>si-local-file:///var/storage/secattach/20250814/25199561.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++RetinalGenix+Technologie++For%3A+Jun+30/25199561.html</guid>
   <pubDate>Thu, 14 Aug 2025 06:09:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  NT 10-Q    RetinalGenix Technologie  For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++RetinalGenix+Technologie++For%3A+Jun+30/25199561.html</link>
   <description>si-local-file:///var/storage/secattach/20250814/25199561.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++RetinalGenix+Technologie++For%3A+Jun+30/25199561.html</guid>
   <pubDate>Thu, 14 Aug 2025 06:09:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  144        RetinalGenix Technologie               Filed by: BAYERN STEVEN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/25189516.html</link>
   <description>si-local-file:///var/storage/secattach/20250812/25189516.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/25189516.html</guid>
   <pubDate>Tue, 12 Aug 2025 16:39:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  144        RetinalGenix Technologie               Filed by: BAYERN STEVEN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/25189516.html</link>
   <description>si-local-file:///var/storage/secattach/20250812/25189516.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++RetinalGenix+Technologie+++++++++++++++Filed+by%3A+BAYERN+STEVEN/25189516.html</guid>
   <pubDate>Tue, 12 Aug 2025 16:39:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  EFFECT     RetinalGenix Technologie             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++RetinalGenix+Technologie+++++++++++++/24993842.html</link>
   <description>si-local-file:///var/storage/secattach/20250630/24993842.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++RetinalGenix+Technologie+++++++++++++/24993842.html</guid>
   <pubDate>Mon, 30 Jun 2025 06:02:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  EFFECT     RetinalGenix Technologie             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++RetinalGenix+Technologie+++++++++++++/24993842.html</link>
   <description>si-local-file:///var/storage/secattach/20250630/24993842.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++RetinalGenix+Technologie+++++++++++++/24993842.html</guid>
   <pubDate>Mon, 30 Jun 2025 06:02:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
  <item>
   <title>Form  EFFECT     RetinalGenix Technologie             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++RetinalGenix+Technologie+++++++++++++/24993843.html</link>
   <description>si-local-file:///var/storage/secattach/20250630/24993843.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++RetinalGenix+Technologie+++++++++++++/24993843.html</guid>
   <pubDate>Mon, 30 Jun 2025 06:02:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50735116</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RTGN</category>
   	  </item>
 </channel>
</rss>
